Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4333995 | 0.81 | — | — | |
| SCHEMBL4336277 | 0.80 | — | — | |
| SCHEMBL31309841 | 0.79 | THRB (0.30) | ALDH1A1 | |
| SCHEMBL685637 | 0.78 | — | — | |
| SCHEMBL12432884 | 0.77 | — | — | |
| SCHEMBL454650 | 0.76 | THRB (0.30) | ALDH1A1 | |
| SCHEMBL4320057 | 0.75 | — | — | |
| SCHEMBL284284 | 0.75 | NAAA (0.32) | — | |
| SCHEMBL7182277 | 0.74 | — | — | |
| SCHEMBL822780 | 0.74 | ALDH1A1 (0.36) | MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7511177-B2 | Fluoroadamantane derivative | ASAHI GLASS COMPANY, LIMITED (JP) | 2009-03-31 | — | — | US | disclosed |
| US-7402714-B2 | Fluoroadamantane derivative | ASAHI GLASS COMPANY, LIMITED (JP) | 2008-07-22 | — | — | US | disclosed |
| US-20080132736-A1 | FLUOROADAMANTANE DERIVATIVE | ASAHI GLASS COMPANY, LIMITED (JP) | 2008-06-05 | — | — | US | disclosed |
| US-20070129566-A1 | FLUOROADAMANTANE DERIVATIVE | ASAHI GLASS COMPANY, LIMITED (JP) | 2007-06-07 | — | — | US | disclosed |
| EP-1757575-A1 | FLUOROADAMANTANE DERIVATIVE | Asahi Glass Company, Limited (JP) | 2007-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132736-A1 | FLUOROADAMANTANE DERIVATIVE | AFF1, AFF2, AFF4 | MEN1 1727/4885ALDH1A1 175/4885KMT2A 922/4885 |
| US-20070129566-A1 | FLUOROADAMANTANE DERIVATIVE | AFF1, AFF2, AFF4 | MEN1 1727/4885ALDH1A1 175/4885KMT2A 922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.